Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 1:03 AM
Ignite Modification Date:
2025-12-25 @ 1:03 AM
NCT ID:
NCT04437693
Eligibility Criteria:
Inclusion Criteria:
* 18 years or older, all healthcare workers in direct contact with COVID-19 patients (ex: physicians, nurses, pharmacists, etc.), the ability to swallow Oral medications, without any GI abnormalities that may affect absorption. Who agree to participate in the trial.
Exclusion Criteria:
* Allergy to HCQ.
* Pregnancy or breastfeeding.
* Known history of Retinal disease not related to Macular degeneration, or preexisting eye retinopathy.
* Having a prior history of blood disorders such as aplastic anemia, agranulocytosis, leukopenia, or thrombocytopenia.
* Having a prior history of glucose-6-phosphate dehydrogenase (G-6-PD) deficiency.
* Having dermatitis, psoriasis, or porphyria.
* History of lung disease or Pneumonia not related to COVID-19.
* Taking CYP450 enzyme-inducing medications within 4 weeks of the start of taking HCQ (Ex: Phenytoin, Carbamazepine, Phenobarbital, Primidone or Oxcarbazepine.
* Currently taking QT-prolonging medications, which may include Antiarrhythmics, Quinolones, Macrolides, select Antipsychotics and Antidepressants.
* Team members planning to have major abdominal, thoracic, spine or CNS surgery during the protocol period
Healthy Volunteers:
True
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
60 Years
Study:
NCT04437693
Study Brief:
Protocol Section:
NCT04437693